David Przelicki
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Developmental Neuroscience top 10%
- Neurogenesis and neuroplasticity mechanisms
Papers in
- Genetics 4
- Glioma Diagnosis and Treatment 4
-
- Cancer, Hypoxia, and Metabolism 1
- Partner nations
- CanadaUnited States
In The Last Decade
David Przelicki
4 papers receiving 760 citations
David Przelicki's Hit Papers
Peers
Comparison fields: 5 of 43
- Genetics 364
- Developmental Neuroscience 34
- Oncology 146
- Cancer Research 75
- Molecular Biology 261
Countries citing papers authored by David Przelicki
This map shows the geographic impact of David Przelicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Przelicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Przelicki more than expected).
Fields of papers citing papers by David Przelicki
This network shows the impact of papers produced by David Przelicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Przelicki. The network helps show where David Przelicki may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Childhood cerebellar tumours mirror conserved fetal transcriptional programs Hit paper breakdown → | 2019 | 321 |
| 2 | 2020 | 189 | |
| 3 | 2019 | 144 | |
| 4 | 2020 | 111 | |
| 5 | 2026 | 0 |
About David Przelicki
David Przelicki is a scholar working on Genetics, Cancer Research, Oncology, Molecular Biology and Nuclear Energy and Engineering, having authored 5 papers that have together received 765 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (1 paper), Epigenetics and DNA Methylation (1 paper), RNA Research and Splicing (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Genetics (364 citations), Developmental Neuroscience (34 citations), Oncology (146 citations), Cancer Research (75 citations) and Molecular Biology (261 citations). David Przelicki has collaborated with scholars based in Canada and United States. Their work appears in journals such as Nature, Nature Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.